A 65 year old asthama paitent comes to opd he has also diabeties mellitus type 2 and a exacreabtion of asthama attack how should i manage the paitent
| Feature | Mild–Moderate | Severe | Life-threatening |
|---|---|---|---|
| Speech | Full sentences | Phrases only | Single words / mute |
| RR | <25/min | ≥25/min | >30/min |
| HR | <110/min | ≥110/min | Bradycardia |
| SpO₂ | ≥92% | <92% | <90% |
| PEFR | >50% predicted | 33–50% | <33% ("near-fatal") |
| Issue | Action |
|---|---|
| Steroid-induced hyperglycemia | Monitor BG every 4–6 hrs; target <180 mg/dL in-hospital |
| Metformin | Hold metformin if patient is hypoxic or unwell (lactic acidosis risk) |
| Insulin | Short-acting insulin sliding scale or correction doses may be needed |
| Stress hyperglycemia | Occurs even without steroids — monitor regardless |
| SGLT2 inhibitors | Hold if patient is unwell/dehydrated (DKA risk) |
| Sulfonylureas | Use cautiously — hypoglycemia risk |
| Drug | Reason to Avoid |
|---|---|
| Non-selective β-blockers (propranolol, atenolol) | Precipitate or worsen bronchospasm — absolutely contraindicated in asthma |
| NSAIDs / Aspirin | ~10% of asthmatics are aspirin-sensitive — avoid unless confirmed tolerant |
| Nebulized atropine | May thicken secretions |
| High-dose oxygen | Over-oxygenation not beneficial; target 94–98% |
Exacerbation → Assess severity → O₂ to SpO₂ 94-98%
→ SABA nebulizer (salbutamol)
→ Add ipratropium if moderate/severe
→ Oral prednisolone 40-50mg
→ CHECK BLOOD GLUCOSE immediately
→ Hold metformin if hypoxic
→ Monitor BG every 4-6 hrs
→ If no improvement → IV Magnesium
→ If still no response → ICU/intubation
Every drug with dose
| Route | Mild–Moderate | Severe |
|---|---|---|
| MDI + spacer | 2–6 puffs (180–540 µg) every 20 min × 3 | Same, repeat aggressively |
| Nebulizer | 2.5 mg every 20 min × 3 doses in 1st hour | 2.5–5 mg every 20 min via nebulizer |
| Continuous nebulization | — | 10–15 mg over 1 hour (with cardiac monitoring) |
| Maintenance | 180 µg (2 puffs) every 4–6 h as needed | — |
⚠️ Adverse effects: tachycardia, palpitations, tremors, hypokalemia — monitor electrolytes especially in diabetics
| Route | Dose | Frequency |
|---|---|---|
| Nebulizer | 0.5 mg | Every 20 min × 3 doses (first hour), then every 2–4 h |
| MDI | 2 puffs (36 µg) | 3–4 times daily |
Add to salbutamol in moderate–severe exacerbation for superior bronchodilation. Stop once patient improves.
| Indication | Dose | Duration |
|---|---|---|
| Acute exacerbation (oral) | 40–60 mg once daily | 5–14 days |
| ED discharge | 40 mg/day | 5–7 days (no taper needed for short course) |
| Cannot swallow / severe | IV Hydrocortisone 100–500 mg every 6–12 h | Until oral tolerated |
| Alternative (dexamethasone) | 12 mg once or twice (equivalent efficacy, shorter course) | 1–2 doses |
⚠️ In T2DM: Steroids will raise blood glucose significantly within hours. Monitor BG every 4–6 hours. Do NOT withhold steroids — the exacerbation takes priority.
| Route | Dose | Rate |
|---|---|---|
| IV infusion | 2 g (2000 mg) | Over 20 minutes |
Use when exacerbation is life-threatening or no response to SABA + steroids after 1 hour. Acts as smooth muscle relaxant (bronchodilator). One dose only in ED.
| Target SpO₂ | Delivery |
|---|---|
| 94–98% | Nasal cannula 2–4 L/min or Venturi mask |
Do NOT aim for 100% — controlled oxygenation is preferred.
| Drug | Dose |
|---|---|
| Budesonide | 0.25–0.5 mg via nebulizer once daily or in 2 divided doses |
| Fluticasone propionate | 50–250 µg, 2 puffs twice daily (max 1000 µg/day) |
| Beclomethasone | 44–88 µg (1–2 puffs) twice daily (max 400 µg twice daily) |
| Ciclesonide | 80 µg twice daily |
Start or increase ICS dose at discharge — reduces risk of future exacerbations.
| Drug | Dose |
|---|---|
| Budesonide/Formoterol (Symbicort) | 80 µg budesonide + 4.5 µg formoterol, 2 puffs twice daily |
| Fluticasone/Salmeterol (Seretide/Advair) | Starting dose based on severity, DPI twice daily |
| Fluticasone furoate/Vilanterol (Breo Ellipta) | 100 µg/25 µg, 1 inhalation once daily |
Preferred long-term regimen in a 65-year-old with moderate–severe asthma.
| Indication | Dose |
|---|---|
| BG 180–250 mg/dL | 4–6 units regular insulin SC |
| BG 251–350 mg/dL | 6–8 units regular insulin SC |
| BG >350 mg/dL | 8–10 units + reassess, consider basal-bolus |
If patient is on oral antidiabetics only at home and develops steroid-induced hyperglycemia, short-acting insulin correction doses are first-line in hospital.
Hold metformin if patient is hypoxic (SpO₂ <94%) or unwell — risk of lactic acidosis. Resume once patient is stable, eating normally, and SpO₂ is maintained.
| Drug | Reason |
|---|---|
| Non-selective β-blockers (propranolol, carvedilol, atenolol) | Cause bronchospasm — absolute contraindication in asthma |
| NSAIDs / Aspirin | May trigger aspirin-exacerbated respiratory disease (~10% of asthmatics) |
| SGLT2 inhibitors (empagliflozin, dapagliflozin) | Hold if unwell/dehydrated — risk of euglycemic DKA |
| Sulfonylureas (glibenclamide, glipizide) | Hypoglycemia risk, especially if patient not eating |
| Theophylline | Narrow therapeutic window, high toxicity — last resort only |
| Drug | Dose | Route | Frequency |
|---|---|---|---|
| Salbutamol | 2.5–5 mg (acute) / 180 µg (maintenance) | Nebulizer / MDI | Every 20 min × 3, then PRN |
| Ipratropium | 0.5 mg | Nebulizer | Every 20 min × 3 |
| Prednisolone | 40–60 mg | Oral | Once daily × 5–14 days |
| Hydrocortisone | 100–500 mg | IV | Every 6–12 h |
| Dexamethasone | 12 mg | Oral/IV | 1–2 doses |
| Magnesium Sulfate | 2 g | IV infusion | Single dose over 20 min |
| Budesonide/Formoterol | 80/4.5 µg | DPI | 2 puffs twice daily |
| Oxygen | — | Mask/Cannula | Titrate to SpO₂ 94–98% |
Genrate a ppt fir me